866-997-4948 (US-Canada Toll Free)

China Medical Information System Industry Report, 2012-2014

Published By :

SinoMarketInsight (SMI)

Published Date : 2012-10-17

Category :

Surgical Equipment

No. of Pages : 96

Product Synopsis

At present, the investment on medical information system in China generally accounts for about 2% of the total medical revenue. The investment scale of medical information system in China is expected to exceed RMB 40 billion in 2015, with CAGR achieving 26.3%. The medical resources are insufficient and unevenly distributed in China. As large hospitals have more doctors and provide better medical services, people prefer large hospitals regardless of the severity of illness; as a result, the facilities such as bed are in serious shortage in large hospitals, while those in small hospitals and community healthcare stations are idle. However, the insufficiency, uneven distribution and low efficiency of medical resources have become a big problem in China, and the integration of... Read More

Table Of Content

Table of Content

1. Overview of Medical Information System
1.1 Definition of Medical Information System
1.2 Classification of Medical Information System

2. Development of Medical Information System in China
2.1 Current Situation of Medical Services
2.1.1 Medical and Health Resource Configuration is Unbalanced
2.1.2 Low Efficiency of Health Care Resources Wastes Resources
2.2 Policies of Medical Information System in China
2.3 Construction Progress of Medical Information System in China
2.3.1 Policies to Promote the Process of Chinese Medical Information System
2.3.2 Capital Input of Chinese Medical Information System
2.4 Competition of Chinese Medical Information System

3. Construction of International Medical Information System
3.1 Progress of Developed Countries Medical Information System
3.1.1 England
3.1.2 USA
3.1.3 Japan
3.1.4 Korea
3.2 Overview of American Medical Information System
3.2.1 Present Situation
3.2.2 Market Distribution
3.3 Comparison of Chinese and American Medical Information System

4. Development Trend of Chinese Medical Information System
4.1 Chinese Medical Information System is Expected to Fast Grow
4.1.1 HIS, CIS will Expand the Market Capacity
4.1.2 MIS and CIS Integration is Low
4.2 Accelerated the Construction of Primary Health Institutions
4.3 Social Security Card Promote Information System Comprehensive Upgrade
4.4 Leading Enterprises will Increase Market Share

5. Analysis of Key Enterprises
5.1 Winning Software
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Clients and Suppliers
5.1.5 Prospects and Performance Prediction in 2012-2014
5.1.6 Shareholding Companies
5.2 Neusoft Medical
5.2.1 Profile
5.2.2 Operation
5.2.3 Development Prospects of Xikang Health Management Platform
5.2.4 Development Prospects of Medical System Business
5.3 DHC
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Clients
5.3.5 Prospects and Performance Prediction in 2012-2014
5.3.6 Development Prospects
5.4 Tianjian Technology
5.4.1 Profile
5.4.2 Development Prospects
5.5 Wonders Information
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Clients and Suppliers
5.5.5 Prospects and Performance Prediction in 2012-2014
5.5.6 Equity Investment Projects
5.6 UFIDA Healthcare
5.6.1 Profile
5.6.2 Development Prospects
5.7 Enjoyor Share
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Clients
5.7.5 Prospects and Performance Prediction in 2012-2014
5.8 Yilianzhong
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Prospects and Performance Prediction in 2012-2014
5.8.5 Shareholding Companies
5.9 Zhonglian Soft
5.9.1 Profile
5.9.2 Development Prospects
5.10 Kingdee Medical
5.10.1 Profile
5.10.2 Development Prospects

List of Tables


Classification of Medical Information System
Classification, Function and Subsystem of Medical Information in Narrow Sense
Total Number of Healthcare Institutions in China, 2006-2010
Number of Hospitals in China by Type, 2011
Number of Healthcare Institutions and Beds in China, 2009-2010
Number of Beds in Healthcare Institutions by Region in China (per Thousand Population), 2009
Medical Service Workloads and Bed Occupancy Rate of Hospital in China (by Level)
Medical Expenses and % of GDP in China, 2008-2011
Treatment Flow of One Hospital in China
Medical Information System Solutions for Easing Difficulty in Seeing a Doctor
Policies on Medical Information in China, 2011
Policies on Medical Information in China, 2002-2010
Comparison of Clinical Information Subsystems by Coverage, 2007 and 2010
Chinese Tertiary Hospitals Attention to Medical Information System Products
China's Financial Budget and Final Accounts, 2011
Hospital Information System Investment in China by Region
Funds of Different Levels of Hospitals Investing in Information System in China, 2009
Revenue Scale of Leading Medical Information Providers in China, 2011
Medical Expenses in the USA, 1970-2010
IT Budget of Hospitals in the USA, 2010
Industry Chain Distribution of Medical IT Suppliers in the USA
IT Solutions Market Size in China Medical Treatment Industry, 2009-2014E
China's Investments in Medical Information System, 2010-2015
Implementation of Clinical Information System in Chinese Hospitals, 2010
Construction of Rural Three-level Medical System in China, 2009-2010
Construction of Sanitation Service System in Communities around China, 2009-2010
Average Health Expenditure Constitutes in China, 2010
Employees and R&D Investment of Winning, 2008-2011
Categories and Functions of Winning Software Product
Financial Data of Winning, 2008-2012
Revenue Structure of Winning by Product, 2008-2012
Gross Margin of Winning by Product, 2008-2012
Revenue Structure of Winning by Region, 2008-2012
Revenue Contribution of Winnings Top 5 Clients, H1 2012
Revenue Contribution of Winnings Top 5 Clients, 2011
Procurement Amount of Winnings Top 5 Suppliers, 2011
Performance Prediction of Winning, 2012-2014
Net Income of Winnings Shareholding Companies, 2010-2011
Revenue and Net Income of Neusoft Medical, 2007-2011
Financial Data of Neusoft Medical, 2008-2012
Employees and R&D Investment of DHC, 2007-2011
Financial Data of DHC, 2007-2012
Revenue Structure of DHC by Product, 2007-2012
Profit & Gross Margin of DHC by Product, 2008-2012
Revenue Structure of DHC by Industry, 2007-2012
Revenue Contribution of DHCs Top 5 Clients, H1 2012
Revenue Contribution of DHCs Top 5 Clients, 2011
Performance Prediction of DHC, 2012-2014
Employees and R&D Investment of Wonders Information, 2008-2011
Financial Data of Wonders Information, 2007-2012
Major Business of Wonders Information
Revenue Structure of Wonders Information by Product, 2007-2012
Profit & Gross Margin of Wonders Information by Product, 2008-2012
Revenue Structure of Wonders Information by Region, 2009-2012
Revenue Contribution of Wonders Informations Top 5 Clients, 2011
Procurement Amount of Wonders Informations Top 5 Suppliers, 2011
Performance Prediction of Wonders Information, 2012-2014
Equity Investment Projects and Investment of Wonders Information
Revenue and Net Income of UFIDA Healthcare, 2009-2011
G Series Product System of UF Medical
Employees and R&D Investment of Enjoyor, 2007-2011
Financial Data of Enjoyor, 2007-2012
Revenue Structure of Enjoyor by Product, 2008-2012
Profit & Gross Margin of Enjoyor by Product, 2008-2012
Revenue Structure of Enjoyor by Region, 2007-2012
Name List and Revenue Contribution of Enjoyors Top 5 Clients, H1 2012
Name List and Revenue Contribution of Enjoyors Top 5 Clients, 2011
Performance Prediction of Enjoyor, 2012-2014
Employees and R&D Investment of Yilianzhong 2009-2011
Financial Data of Yilianzhong, 2007-2012
Revenue Structure of Yilianzhong by Product, 2007-2012
Revenue Structure of Yilianzhong by Region, 2007-2012
Performance Prediction of Yilianzhong, 2012-2014
Yilianzhong Issued 700 Million New Cards to Estimate the Corresponding Market
Net Income of Yilianzhongs Shareholding Companies, 2010-2011
Products and Solutions of Zhonglian Soft

List of Figures

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Greece: lemons and limes market

    By - Williams and Marshal Strategy

    This report presents a comprehensive overview of the lemons and limes market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the lemons and limes market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...

  • Geriatric Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Geriatric is the branch of medicine concerned with clinical, remedial, preventive and social aspects of illness usually among people over 65 years of age. In response to the needs and demands of an aging population, demand for geriatric medicines has grown rapidly in last 3 decades. The elderly patients across the globe face an array of ill health conditions which include co-morbid complexities such as falls, cerebral ageing and syncope among others. According to Eurostat the number of people aged 65 tears and above is likely to be 141 million by 2050 which is approximately...

  • Anti Peptic Ulcer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    An anti-peptic ulcer drug is a class of drugs used for the treatment of most common ulcers in stomach and upper part of small intestine. These drugs act by decreasing the levels of gastric acidity or by enhancing the protection for mucosa. Major causes of peptic ulcer are Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs). Anti-peptic ulcer drugs market is classified based on: Drug class Proton pump inhibitor H2 receptor antagonist Gastric mucosal protective...